-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-E-1-E-4.xlsx
January 01, 2023 - study enrollment Median 64 13 NR NR NR NR NR NR NR Patients with major psychiatric disorder or past drug … preparation Mean 50 23 NR NR NR NR NR Mean 48 Patients with bipolar disorder or psychosis excluded Comparison drug
-
effectivehealthcare.ahrq.gov/health-topics/autoimmune-diseases
-
effectivehealthcare.ahrq.gov/health-topics/acute-myeloid-leukemia
-
effectivehealthcare.ahrq.gov/health-topics/giardia-infections
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/instrumental-variable-methods_research.pdf
April 01, 2010 - We anticipate that IV methods will be often underpowered for drug safety studies of very rare
outcomes … The new drug is added to the formulary in some hospitals; however, because of cost and
concerns about … Variation in formularies, hospital capacity, and prescription drug benefit plan
structure can also … Pharmacoepidemiol
Drug Saf 2009;18:932-940.
37. Korn EL, Baumrind S. … Drug copayment and adherence in chronic
heart failure: effect on cost and outcomes.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/lung-cancer-nonsurgical-therapies_executive.pdf
June 01, 2013 - Food and Drug Administration Web site,
ClinicalTrials.gov, and conference abstracts (American
Society
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/trauma-interventions-maltreatment-child_executive.pdf
April 01, 2013 - Childhood victimization
and illicit drug use in middle adulthood.
-
effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-hospital-length-of-stay.pdf
November 01, 2019 - Does the nomination
represent a health care
drug, intervention,
device, technology, or
health care
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hip-feature-treatment-future_research.pdf
September 23, 2010 - As part of the Medicare Prescription Drug, Improvement, and Modernization
Act of 2003, Congress directed
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/febrile-infants-diagnosis-management_executive.pdf
March 01, 2012 - In one study,
0.4 percent of the included infants developed drug-related
rash and 18.9 percent had
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/dental-post-transplant-complications-rapid-research.pdf
May 01, 2025 - Drug-Induced Gingival
Hyperplasia in Transplant Recipients.
-
effectivehealthcare.ahrq.gov/health-topics/hivaids
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_disposition-comments.pdf
September 25, 2013 - However, clopidogrel metabolism is also influenced by
drug-drug interactions such as PPIs, calcium channel … While
concluding their argument, the authors ignored many important
things including the role of drug-drug … We agree that drug-drug, gene-drug, or other interactions
are potentially affecting the prognostic value … Ticagrelor is a direct drug although the active
metabolite is as potent as native clopidogrel. … Therefore, it is
important for measurement of the drug effect to be highly
specific.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/acs-pci-adjunctive-devices_surveillance.pdf
April 01, 2013 - would produce prima facie evidence that a conclusion was out of date,
such as the withdrawal of a drug … Is the portion of the CER that is
probably or certainly out of date an issue of safety (a drug withdrawn … from the market, a
black box warning) or the availability of a new drug within class (the latter being … original key questions, the conclusions of the original report, the results of
the literature and drug … aspiration
thrombectomy
Vink, 20125
(PASSION)
Post hoc analysis of RCT Patients being randomized to drug
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_addendum.pdf
February 01, 2010 - As part of the Medicare Prescription Drug, Improvement, and Modernization
Act of 2003, Congress directed … We have no data on concomitant drug treatment or on control
of coronary risk factors during follow-up … None of the ten trials included in this study used drug-eluting stents for PCI. … stents,36 trials that compare CABG with
PCI by use of drug-eluting stents are still in progress.33,37 … A
hierarchical Bayesian meta-analysis of
randomised clinical trials of drug-eluting
stents.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antidepressants-2007_executive.pdf
January 01, 2007 - We
assessed statistically each of the 66 possible drug
comparisons of second-generation antidepressants … Direct evidence from head-to-head trials was
considered sufficient to conduct meta-analyses for four
drug-drug … Issues
We found no studies that identified reliable predictors
of individual responses to a specific drug … , many patients try multiple antidepressant
medications before finding an effective, well-tolerated
drug … , but predicting which drug will be most effective
or best tolerated in any given individual is not yet
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-disease-ace-inhibitor-arb-disposition.pdf
March 10, 2010 - The EPC first looks at the universe of studies of
ACE inhibitors and ARBs before assessing the two drug … One cannot assume that two different classes of drug are
interchangeable, thus justifying combining … providing an initial analysis with both ACE
inhibitors and ARBs and then providing them with each drug … - aldosterone system
(RAAS) antagonists provide benefits and there are only two RAAS
antagonistic drug … The
initial and target doses vary for each drug, depending on whether it is
used for HTN, HF, or left
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c_research-protocol.pdf
November 30, 2011 - .); effects of dose and duration of therapy; and benefits and harms of different
combinations of drug … Population(s):
Non-co-infected adults with HCV infection who have not had previous antiviral drug … US Food and Drug Administration. FDA approves Incivek for hepatitis C. … US Food and Drug Administration. FDA approves Victrelis for hepatitis C. … Drug Class Review on Pegylated Interferons for
Hepatitis C. 2007.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_executive.pdf
July 01, 2009 - study in 1998, Haissaguerre and
colleagues studied 45 patients with paroxysmal AF
(PAF) refractory to drug … comparing 8 mm tip catheters to irrigated (closed or
open) tip catheters in patients undergoing PVI for drug … There is a low level of evidence suggesting no
differences in rhythm control in patients with drug-
refractory … patients in each trial
did not show significant differences in the outcomes of
PVI in patients with drug-refractory
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-illness-heart_executive.pdf
April 01, 2013 - identify relevant gray
literature: (1) a request for scientific information packets
submitted to drug … The drug classes in our review
sometimes included drugs with diverse mechanisms
of action. … When results varied by drug, we assigned
separate SOE. … Impaired fasting glucose
tolerance in first-episode, drug-naive patients with schizophrenia. … Pharmacoepidemiol Drug Saf.
2011;20(1):66-75. PMID: 21182154.
62.